Quebec City, Canada – January 8th, 2023 – The Research Center of the CHU de Québec – Université Laval is pleased to announce a collaborative project with Verily, an Alphabet precision health technology company, aimed at applying cutting-edge precision analysis technologies to enhance skin health.
This strategic research collaboration will support the My Skin & Hair Journey study, which Verily launched with L’Oreal earlier this year, which involves the long-term assessment of thousands of participants to better understand the mechanisms associated with skin health and the aging process. The Research Center of the CHU de Québec – Université Laval is responsible for biological sample processing and analysis in accordance with the scientific objectives of the program.
The Research Center of the CHU de Québec – Université Laval is nationally and internationally recognized for its expertise in developing and implementing “omics” analysis technologies, including genomics, transcriptomics, and proteomics, as well as their processing through bioinformatics and artificial intelligence. This expertise, combined with Verily and L’Oréal’s scientific knowledge, will be a significant asset in decoding the deep biology of the skin.
Professor Arnaud Droit from the Faculty of Medicine at Université Laval will lead this new collaboration. He will mobilize four state-of-the-art technology platforms within our research center: gene expression, next-generation sequencing, proteomics, and bioinformatics, all equipped with the latest instruments and highly qualified personnel.
“This new collaboration will position the Research Center of the CHU de Québec – Université Laval as a key collaborator of Verily in the development of research for dermatology and skin care. It will establish us as a global leader in the use of ‘omics’ technologies and AI for human health,” states Professor Arnaud Droit.
About Centre de recherche du CHU de Québec-Université Laval
The largest French-language research center in North America, the Centre de recherche du CHU de Québec-Université Laval brings together 1,016 researchers, 1,499 employees and 1,185 graduate students at five sites in Quebec City. With research revenues of nearly $137 million, it ranks second in Quebec and eighth in Canada in the Top 40 Research Hospitals 2022. Thanks to the excellence of its research teams and state-of-the-art facilities, the organization enjoys an enviable national and international reputation. www.crchudequebec.ulaval.ca